These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 23711354)

  • 1. Insights on altered mitochondrial function and dynamics in the pathogenesis of neurodegeneration.
    McInnes J
    Transl Neurodegener; 2013 May; 2(1):12. PubMed ID: 23711354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer's Disease and Parkinson's Disease.
    Monzio Compagnoni G; Di Fonzo A; Corti S; Comi GP; Bresolin N; Masliah E
    Mol Neurobiol; 2020 Jul; 57(7):2959-2980. PubMed ID: 32445085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
    Hashimoto M; Rockenstein E; Crews L; Masliah E
    Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Broad Impact of TOM40 on Neurodegenerative Diseases in Aging.
    Gottschalk WK; Lutz MW; He YT; Saunders AM; Burns DK; Roses AD; Chiba-Falek O
    J Parkinsons Dis Alzheimers Dis; 2014 Nov; 1(1):. PubMed ID: 25745640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
    Reddy PH; Oliver DM
    Cells; 2019 May; 8(5):. PubMed ID: 31121890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AD-linked, toxic NH2 human tau affects the quality control of mitochondria in neurons.
    Amadoro G; Corsetti V; Florenzano F; Atlante A; Ciotti MT; Mongiardi MP; Bussani R; Nicolin V; Nori SL; Campanella M; Calissano P
    Neurobiol Dis; 2014 Feb; 62():489-507. PubMed ID: 24411077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PARIS induced defects in mitochondrial biogenesis drive dopamine neuron loss under conditions of parkin or PINK1 deficiency.
    Pirooznia SK; Yuan C; Khan MR; Karuppagounder SS; Wang L; Xiong Y; Kang SU; Lee Y; Dawson VL; Dawson TM
    Mol Neurodegener; 2020 Mar; 15(1):17. PubMed ID: 32138754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial Calcium Dysregulation Contributes to Dendrite Degeneration Mediated by PD/LBD-Associated LRRK2 Mutants.
    Verma M; Callio J; Otero PA; Sekler I; Wills ZP; Chu CT
    J Neurosci; 2017 Nov; 37(46):11151-11165. PubMed ID: 29038245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances.
    Wang W; Zhao F; Ma X; Perry G; Zhu X
    Mol Neurodegener; 2020 May; 15(1):30. PubMed ID: 32471464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synaptic mitochondria in synaptic transmission and organization of vesicle pools in health and disease.
    Vos M; Lauwers E; Verstreken P
    Front Synaptic Neurosci; 2010; 2():139. PubMed ID: 21423525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial Biology and Neurological Diseases.
    Arun S; Liu L; Donmez G
    Curr Neuropharmacol; 2016; 14(2):143-54. PubMed ID: 26903445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease.
    Yan MH; Wang X; Zhu X
    Free Radic Biol Med; 2013 Sep; 62():90-101. PubMed ID: 23200807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the association between alpha-synuclein and tau with mitochondrial dysfunction: Implications for Parkinson's disease.
    Feng ST; Wang ZZ; Yuan YH; Sun HM; Chen NH; Zhang Y
    Eur J Neurosci; 2021 May; 53(9):2946-2959. PubMed ID: 32031280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamate excitotoxicity in neurons triggers mitochondrial and endoplasmic reticulum accumulation of Parkin, and, in the presence of N-acetyl cysteine, mitophagy.
    Van Laar VS; Roy N; Liu A; Rajprohat S; Arnold B; Dukes AA; Holbein CD; Berman SB
    Neurobiol Dis; 2015 Feb; 74():180-93. PubMed ID: 25478815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dysfunction in Parkinson's disease.
    Bose A; Beal MF
    J Neurochem; 2016 Oct; 139 Suppl 1():216-231. PubMed ID: 27546335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial dynamics and neurodegeneration.
    Lu B
    Curr Neurol Neurosci Rep; 2009 May; 9(3):212-9. PubMed ID: 19348710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial dysfunctions in Parkinson's disease.
    Gautier CA; Corti O; Brice A
    Rev Neurol (Paris); 2014 May; 170(5):339-43. PubMed ID: 24119854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.